MedPath

Comparison of the pregnancy outcomes in patients with the polycystic ovarian syndrome in two endometrial preparation method GnRHagonist plus hormone replacement therapy versus hormone replacement therapy frozen embryo transfer cycle

Phase 3
Conditions
Infertility.
Female infertility associated with anovulation
N97.0
Registration Number
IRCT20090526001952N15
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
124
Inclusion Criteria

The first or second cycle of embryo transfer
Normal uterine cavity
PCO diagnosis based on Rotterdam criteria and correction (2018)
Age 20 to 40 years

Exclusion Criteria

Infertility with severe male factor
endometriosis
immunological disease
FSH higher than 10
BMI greater than or equal to 30
Endometrial thickness on the day of transfer is less than 7 mm
History of recurrent miscarriage

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: On the day of transfer. Method of measurement: transvaginal ultrasound.;Chemical pregnancy. Timepoint: 14 days after transfer. Method of measurement: Beta HCG Test.;Clinical pregnancy. Timepoint: 7 weeks of pregnancy. Method of measurement: Transvaginal Ultrasound.;Ongoing pregnancy. Timepoint: 12 weeks of pregnancy. Method of measurement: Ultrasonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath